Andrew Y Chang
Overview
Explore the profile of Andrew Y Chang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
340
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schulman E, Chen K, Chang A
Health Serv Res
. 2024 Nov;
60(1):e14408.
PMID: 39539050
No abstract available.
2.
Doh C, An C, Chang A, Rwebembera J, Mwambu T, Beaton A, et al.
Ann Thorac Surg
. 2024 Jun;
118(4):941-948.
PMID: 38908768
Background: There is an unmet surgical burden among people living with rheumatic heart disease (RHD) in Uganda. Nevertheless, risk factors associated with time to first intervention and preoperative mortality are...
3.
Opara C, Lan R, Rwebembera J, Okello E, Watkins D, Chang A, et al.
Heart Rhythm O2
. 2024 May;
5(4):201-208.
PMID: 38690140
Background: Atrial fibrillation (AF) is a common complication of rheumatic heart disease (RHD) and is challenging to treat in lower-resourced settings in which RHD remains endemic. Objective: We characterized demographics,...
4.
Rwebembera J, Chang A, Kitooleko S, Kaudha G, de Loizaga S, Nalule M, et al.
Glob Heart
. 2023 Nov;
18(1):62.
PMID: 38028964
Background: Chronic valvular heart disease is a well-known, long-term complication of acute rheumatic fever (ARF), which remains a major public health problem in low- and middle-income countries. Access to surgical...
5.
Geldsetzer P, Flores S, Flores B, Rogers A, Chang A
PLOS Digit Health
. 2023 Oct;
2(10):e0000156.
PMID: 37801442
Communicable diseases remain a leading cause of death and disability in low- and middle-income countries (LMICs). mHealth technologies carry considerable promise for managing these disorders within resource-poor settings, but many...
6.
Chang A, Rahman M, Talukder A, Shah H, Mridha M, Hasan M, et al.
Trials
. 2023 Jul;
24(1):480.
PMID: 37501102
Background: High blood pressure is a major public health problem in low- and middle-income countries. Low-sodium salt substitute (LSSS) is a promising population-level blood pressure-lowering intervention requiring minimal behavioral change....
7.
Gribben V, Chang A, Ling P, Rasmussen J, Tebb K, Fuentes-Afflick E, et al.
MedEdPORTAL
. 2023 May;
19:11313.
PMID: 37228253
Introduction: Children's exposure to secondhand smoke is an underaddressed public health threat. The Clinical Effort Against Secondhand Smoke Exposure (CEASE) is a validated framework that trains pediatric providers to screen,...
8.
Chang A, Zuhlke L, Ribeiro A, Barry M, Okello E, Longenecker C
Am J Trop Med Hyg
. 2023 Feb;
108(3):462-464.
PMID: 36746666
The COVID-19 pandemic has profoundly influenced the effort to achieve global health equity. This has been particularly the case for HIV/AIDS, tuberculosis, and malaria control initiatives in low- and middle-income...
9.
Fang Y, Chang A, Verma D, Miyashita S, Eszterhas S, Lee P, et al.
ACS Synth Biol
. 2023 Jan;
12(1):153-163.
PMID: 36623275
Botulinum neurotoxin serotype A (BoNT/A) is a widely used cosmetic agent that also has diverse therapeutic applications; however, adverse antidrug immune responses and associated loss of efficacy have been reported...
10.
Collins W, Chang A, Weng Y, Dahlen A, OBrien C, Hom J, et al.
J Obes Metab Syndr
. 2022 Sep;
31(3):277-281.
PMID: 36058896
Background: The mechanism for possible association between obesity and poor clinical outcomes from Coronavirus Disease 2019 (COVID-19) remains unclear. Methods: We analyzed 22,915 adult COVID-19 patients hospitalized from March 2020...